April Sorrell

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing et al. · Blood · 2011 · 230 citations · Full text

Medicine, Hematology, Pediatrics +9

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Jeffrey W. Taub, Jason N. Berman, Johann Hitzler et al. · Blood · 2017 · 109 citations · Full text

Medicine, Hematology, Oncology +13

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

Linda C. Stork, Yousif Matloub, Emmett Broxson et al. · Blood · 2010 · 101 citations · Full text

Medicine, Oncology, Pediatrics +15

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971

April Sorrell, Todd A. Alonzo, Joanne M. Hilden et al. · Cancer · 2012 · 83 citations · Full text

Medicine, Oncology, Pediatrics +17

First Results of Iberdomide (IBER; CC-220) in Combination with Dexamethasone (DEX) and Daratumumab (DARA) or Bortezomib (BORT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Niels W.C.J. van de Donk, Rakesh Popat, Jeremy T. Larsen et al. · Blood · 2020 · 47 citations

Medicine, Pharmacology, Pharmacotherapy +14